Wei Liang

Wei Liang

Auto-generated profile, based on publicly available information

Wei Liang

Shanghai Clinical Research and Trial Center, Shanghai, China

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

18 September 2025 in Cancer Immunology Research
Verified
Journal Article
Open access
XMXin Ma
Xin Ma
YLYumei Liu
Yumei Liu
YCYingying Chen
Yingying Chen
JWJuan Wang
Juan Wang
FZFeiyue Zhang
Feiyue Zhang
JWJiajia Wang
Jiajia Wang
The immunosuppressive tumor microenvironment remains a major barrier to effective immunotherapy in gastric cancer. In this study, we identified the E3 ubiquitin ligase BFAR as a critical regulator of neutrophil-mediated immune evasion through the S100A8/A9–BFAR–PRP19–YBX1 signaling axis. Multiomics analyses revealed that BFAR is overexpressed in gastric cancer and correlates with poor prognosis. Functional studies demonstrated that BFAR knockdown suppressed tumor growth by reducing neutrophil infiltration and immunosuppressive reprogramming to restore CD8+ T-cell function. Mechanistically, BFAR mediated K48-linked ubiquitination and degradation of PRP19, leading to stabilization of the oncoprotein YBX1, which transcriptionally upregulated neutrophil-recruiting chemokines CXCL1/CXCL3. Infiltrating neutrophils secreted S100A8/A9, which activated NF-κB to induce BFAR expression in tumor cells and created a feed-forward loop that sustains an immunosuppressive tumor microenvironment. Furthermore, BFAR promoted neutrophil PD-L1 expression via GM-CSF, reinforcing T-cell exhaustion. Clinically, BFAR expression correlated with neutrophil infiltration and poor response to anti–PD-1 therapy, whereas its inhibition synergizes with immune checkpoint blockade in preclinical models. Our work unveils BFAR as a central orchestrator of neutrophil-driven immunosuppression and proposes targeting this axis to enhance immunotherapy efficacy in gastric cancer.



2 December 2025
Verified
Other
Open access
XMXin Ma
Xin Ma
YLYumei Liu
Yumei Liu
YCYingying Chen
Yingying Chen
JWJuan Wang
Juan Wang
FZFeiyue Zhang
Feiyue Zhang
JWJiajia Wang
Jiajia Wang
Supplementary Figure 3. Infiltration of macrophages and T cells is independent of BFAR

2 December 2025
Verified
Other
Open access
XMXin Ma
Xin Ma
YLYumei Liu
Yumei Liu
YCYingying Chen
Yingying Chen
JWJuan Wang
Juan Wang
FZFeiyue Zhang
Feiyue Zhang
JWJiajia Wang
Jiajia Wang
Supplementary Figure 4. Bfar knockdown restrains the neutrophil chemokines expressions